SCHEMBL7061600

SCHEMBL7061600

CC(=O)OCCOC(=O)N[C]=N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
TSHR P16473 1/20 0.43
CHRM5 P08912 3/20 0.39
CHRM1 P11229 3/20 0.39
CHRM3 P20309 3/20 0.39
CHRM2 P08172 2/20 0.39
CHRM4 P08173 2/20 0.39
CHRNB2 P17787 2/20 0.39
CHRNA7 P36544 2/20 0.39
CHRNA4 P43681 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PGR P06401 1/20 0.39
HTR1A P08908 1/20 0.39
TBXA2R P21731 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA10 Q9GZZ6 1/20 0.39
CHRNA9 Q9UGM1 1/20 0.39
GALR3 O60755 2/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208478 0.76
SCHEMBL64593 0.74 ALDH1A1 (0.68) ALDH1A1TSHRCHRM5CHRM1CHRM3
SCHEMBL21123435 0.73 CHRNB2 (0.56) ALDH1A1TSHRCHRM5CHRM1CHRM3
Acetic Acid Methyl Ester SCHEMBL16593614 0.71 ALDH1A1 (0.62) ALDH1A1TSHRCHRM5CHRM1CHRM3
Hydrochloric Acid SCHEMBL26134181 0.71 ALDH1A1 (0.65) ALDH1A1TSHRCHRM5CHRM1CHRM3
Ammonia Solution, Strong SCHEMBL5679172 0.71 ALDH1A1 (0.65) ALDH1A1TSHRCHRM5CHRM1CHRM3
SCHEMBL29446779 0.71 ALDH1A1 (0.65) ALDH1A1TSHRCHRM5CHRM1CHRM3
SCHEMBL28095156 0.70 ALDH1A1 (0.52) ALDH1A1TSHRCHRM5CHRM1CHRM3
Methoxymethane SCHEMBL2501432 0.69 ALDH1A1 (0.62) ALDH1A1TSHRCHRM5CHRM1CHRM3
Ethylene SCHEMBL8445487 0.69 ALDH1A1 (0.62) ALDH1A1TSHRCHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030199698-A1 Carbamic acid esters as inhibitors of factor xa MERCK PATENT GMBH (DE) 2003-10-23 US disclosed
US-20030166694-A1 Glycinamides MERCK PATENT GMBH (DE) 2003-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199698-A1 Carbamic acid esters as inhibitors of factor xa F11, F12, F13A1 ALDH1A1 985/4885TSHR 826/4885CHRM5 1092/4885
US-20030166694-A1 Glycinamides F11, SERPINC1, F13A1 ALDH1A1 540/4885TSHR 1127/4885CHRM5 2794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.